SEC Form 4 · accession 0001193125-26-330503
Apnimed, Inc. · APMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William A Jones Jr.
Director
Period of report
Jul 30, 2026
Accepted (ET)
Aug 3, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001745648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $16.00 | Jul 30, 2026 | A | 44,477 | A | — | Jul 29, 2036 | Class A Common Stock | 44,477 | 44,477 | D |
| Stock Option (Right to Buy)F2 | $16.00 | Aug 3, 2026 | D | 44,477 | A | — | Jul 29, 2036 | Class A Common Stock | 44,477 | 0 | D |
| Stock Option (Right to Buy)F2 | $16.00 | Aug 3, 2026 | A | 44,477 | A | — | Jul 29, 2036 | Common Stock | 44,477 | 44,477 | D |
Explanation of responses
- F1Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
- F2The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.